At the recent American Academy of Allergy, Asthma & Immunology (AAAAI) annual meeting, researchers reported that treatment with benralizumab (Fasenra) was noninferior to mepolizumab (Nucala) for ...

Please provide your email address to receive an email when new articles are posted on . Patients began with mepolizumab or benralizumab before switching to continuing with benralizumab at week 52.

In a study spanning almost three decades, the use of interferon alfa-2b led to durable remission for patients with low-grade lymphomatoid granulomatosis and increased overall survival compared with ...

Please provide your email address to receive an email when new articles are posted on . Systemic corticosteroid use decreased with mepolizumab treatment. Mean daily oral corticosteroid use fell by 18% ...

Symptoms of Granulomatosis with Polyangiitis (GPA) are usually related to the upper airways, lungs and kidneys. Granulomatosis with Polyangiitis (GPA) affects the upper airways, lungs and kidneys.

Orofacial Granulomatosis (OFG) and Melkersson-Rosenthal Syndrome (MRS) represent rare, chronic conditions that affect the orofacial region. OFG is characterised by persistent or recurrent soft tissue ...

Introduction: Granulomatosis with polyangiitis (GPA) is an autoimmune disease leading to necrotizing lesions in the affected tissues. Computed tomography (CT) of paranasal sinuses reveals multiple ...

This page lists all known medications that could potentially lead to 'Wegener's granulomatosis' as a side effect. It's important to note that mild side effects are quite common with medications. The ...

Wegener's granulomatosis (newly renamed granulomatosis with polyangiitis [WG/GPA]) is a granulomatous autoimmune inflammatory disorder of unknown etiology that is associated with anti-neutrophil ...

Patients with Wegener's granulomatosis often undergo treatment with cyclophosphamide in order to induce disease remission. Methotrexate and leflunomide have been proposed for maintaining remission ...

A 26-year-old man was urgently admitted to our cardiology department due to cardiogenic shock in the course of a third-degree atrioventricular block (Figure 1A), with ventricular rate of 20–25 bpm.

We report an unusual case of Langerhans cell granulomatosis (LCG) manifested as a villous synovial proliferation in a 38-year-old female jogger. One year after the onset of joint symptoms, she had a ...